BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16202587)

  • 1. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
    Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the preparation of radiolabeled 1-aryl-3-benzyl ureas: Radiosynthesis of [(11)C-carbonyl] AR-A014418 by [(11)C]CO(2) fixation.
    Hicks JW; Wilson AA; Rubie EA; Woodgett JR; Houle S; Vasdev N
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2099-101. PubMed ID: 22321216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice.
    Martins DF; Rosa AO; Gadotti VM; Mazzardo-Martins L; Nascimento FP; Egea J; López MG; Santos AR
    J Pain; 2011 Mar; 12(3):315-22. PubMed ID: 20705523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
    Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS
    J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AR-A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury.
    Tunçdemir M; Yıldırım A; Karaoğlan A; Akdemir O; Oztürk M
    Neurocirugia (Astur); 2013; 24(1):22-32. PubMed ID: 23116585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-stress effects of a GSK-3β inhibitor, AR-A014418, in immobilization stress of variable duration in mice.
    Bali A; Jaggi AS
    J Basic Clin Physiol Pharmacol; 2017 Jul; 28(4):315-325. PubMed ID: 28590916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action.
    Mazzardo-Martins L; Martins DF; Stramosk J; Cidral-Filho FJ; Santos AR
    Neuroscience; 2012 Dec; 226():411-20. PubMed ID: 23000630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
    Gould TD; Einat H; Bhat R; Manji HK
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):387-90. PubMed ID: 15315719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
    Rosa AO; Kaster MP; Binfaré RW; Morales S; Martín-Aparicio E; Navarro-Rico ML; Martinez A; Medina M; García AG; López MG; Rodrigues AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1549-56. PubMed ID: 18579278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
    Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
    J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
    Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
    Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
    Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GSK-3β on Behavioral Changes and Oxidative Stress in an Animal Model of Mania.
    Dal-Pont GC; Resende WR; Varela RB; Menegas S; Trajano KS; Peterle BR; Quevedo J; Valvassori SS
    Mol Neurobiol; 2019 Apr; 56(4):2379-2393. PubMed ID: 30027342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and preliminary PET evaluation of glycogen synthase kinase 3β (GSK-3β) inhibitors containing [(11)C]methylsulfanyl, [(11)C]methylsulfinyl or [(11)C]methylsulfonyl groups.
    Kumata K; Yui J; Xie L; Zhang Y; Nengaki N; Fujinaga M; Yamasaki T; Shimoda Y; Zhang MR
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3230-3. PubMed ID: 26067173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of [(11)C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β).
    Cole EL; Shao X; Sherman P; Quesada C; Fawaz MV; Desmond TJ; Scott PJ
    Nucl Med Biol; 2014 Jul; 41(6):507-12. PubMed ID: 24768148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies.
    Pomper MG; Musachio JL; Scheffel U; Macdonald JE; McCarthy DJ; Reif DW; Villemagne VL; Yokoi F; Dannals RF; Wong DF
    J Nucl Med; 2000 Aug; 41(8):1417-25. PubMed ID: 10945536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of glycogen synthase kinase 3 (GSK-3) inhibitors: an fast and atom efficient access to 1-aryl-3-benzylureas.
    Monte FL; Kramer T; Boländer A; Plotkin B; Eldar-Finkelman H; Fuertes A; Dominguez J; Schmidt B
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5610-5. PubMed ID: 21807510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the involvement of glycogen synthase kinase-3β and gap junction signaling in TRPV
    Randhawa PK; Jaggi AS
    Eur J Pharmacol; 2017 Nov; 814():9-17. PubMed ID: 28755986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.